Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 24.50

From 52W high−23.88%

Volume19.93M

Market capCNY 21.54B

P/E (TTM)78.1x

P/S (TTM)8.2x

Div yield0.83%

Key dataSep 18, 2026

Open

CNY 24.50

From 52W high

−23.88%

Volume

19.93M

Market cap

CNY 21.54B

ValuationView details →

P/E (Fwd)

49.7x

EV/EBITDA

48.0x

P/E (TTM)

78.1x

RSI (14)

43.0

MomentumView details →

1D Return

−3.17%

YTD Return

+27.61%

ValuationView details →

P/E (Fwd)

49.7x

P/E (TTM)

78.1x

EV/EBITDA

48.0x

EV/Sales

8.1x

P/S (TTM)

8.2x

P/B (TTM)

5.4x

ProfitabilityView details →

Gross Margin

56.29%

Net Margin

11.66%

EBITDA Margin

16.78%

ROE (TTM)

7.04%

ROA (TTM)

5.48%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

+2.12%

EPS YoY

+207.72%

FCF YoY

+8.86%

Revenue CAGR 3Y

−1.95%

EPS CAGR 3Y

−6.21%

EBITDA YoY

—

MomentumView details →

1D Return

−3.17%

YTD Return

+27.61%

1Y Return

+22.57%

RSI (14)

43.0

vs 50D SMA

−9.29%

vs 200D SMA

+8.38%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

4.14x

Quick Ratio

3.71x

Div Yield

0.83%

Div Rate

CNY 0.20

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.01

EPS Surprise

−86.03%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.10

Avg Surprise (4Q)

−86.03%

Rev Surprise

−26.25%

Financials snapshotView financials →

Revenue (TTM)

2.51B

Net Income (TTM)

292.97M

Op. CF (TTM)

475.35M

Next earningsNov 3, 2026 →

Latest newsMore news →

Zhongsheng Pharmaceutical provided a joint liability guarantee of 200 million yuan for its wholly-owned subsidiary Guangdong Zhongsheng Pharmaceutical Trading Co., Ltd. for a comprehensive credit line from Bank of Communications Dongguan Branch.17d ago

Zhongsheng Pharmaceutical received approval from China's National Medical Products Administration to add a 0.2g specification of its fenofibrate capsules, deemed consistent with generic drug quality and efficacy.17d ago

Similar companies

宏达电子300726.SZ 航天发展000547.SZ 吉林敖东000623.SZ 常山药业300255.SZ 乐普医疗300003.SZ 万丰奥威002085.SZ Find similar companies →

Latest newsMore news →

Zhongsheng Pharmaceutical provided a joint liability guarantee of 200 million yuan for its wholly-owned subsidiary Guangdong Zhongsheng Pharmaceutical Trading Co., Ltd. for a comprehensive credit line from Bank of Communications Dongguan Branch.17d ago Zhongsheng Pharmaceutical received approval from China's National Medical Products Administration to add a 0.2g specification of its fenofibrate capsules, deemed consistent with generic drug quality and efficacy.17d ago